MIT researchers find blocking the expression of the genes XPA and MK2 enhances the tumor-shrinking effects of platinum-based chemotherapies in p53-mutated cancers.
Physicists Tracy Slatyer and Netta Engelhardt and mathematicians Lisa Piccirillo and Nina Holden PhD ’18 are honored by the Breakthrough Prize Foundation.